American Journal of Ophthalmology
Volume 149, Issue 2 , Pages 221-228.e2 , 1 February 2010

Cost-Effectiveness of the Boston Keratoprosthesis

,Accepted 26 August 2009.

References 

  1. The World Health Organizaiton. Visual impairment and blindness. http://www.who.int/mediacentre/factsheets/fs282/en/Accessed: January 7, 2009
  2. International Classification of Diseases (ICD). The World Health Organization (Chapter VII. Diseases of the eye and adnexa (H00-H59). Visual disturbances and blindness (H53-H54)). http://www.who.int/classifications/icd/en/Accessed: August 14, 2009
  3. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ. 2001;79(3):214–221
  4. Smith GT, Taylor HR. Epidemiology of corneal blindness in developing countries. Refract Corneal Surg. 1991;7:436–439
  5. Upadhyay MP, Karmacharya PC, Koirala S, et al. The Bhaktapur Eye Study: Ocular trauma and antibiotic prophylaxis for the prevention of corneal ulceration in Nepal. Br J Ophthalmol. 2001;85:388–392
  6. Frick KD, Gower EW, Kempen JH, Wolff JL. Economic impact of visual impairment and blindness in the United States. Arch Ophthalmol. 2007;125(4):544–550
  7. Frick KD, Foster A. The magnitude and cost of global blindness: an increasing problem that can be alleviated. Am J Opthalmol. 2003;135:471–476
  8. World Development Report 1993 (Investing in Health). In: New York: Oxford University Press; 1993;p. 23;http://www.dcp2.org/file/62/World%20Development%20Report%201993.pdfAccessed: February 21, 2009
  9. Lansingh VC, Carter MJ, Martens M. Global cost-effectiveness of cataract surgery. Ophthalmology. 2007;114(9):1670–1678
  10. Hirneiss C, Neubauer AS, Niedermeir A, Messmer EM, Ulbig M, Kampik A. Cost utility for penetrating keratoplasty in patients with poor binocular vision. Ophthalmology. 2006;113:2176–2180
  11. Brown MM, Brown GC. How to interpret a healthcare economic analysis. Curr Opin Ophthalmol. 2005;16(3):191–194
  12. Brown GC, Brown MM, Sharma S. Health care economic analyses. Retina. 2004;24(1):139–146
  13. Redelmeier DA, Detsky AS. A clinician's guide to utility measurement. Prim Care. 1995;22(2):271–280
  14. Feeny DH, Torrance DW. Incorporating utility-based quality-of-life assessment measures in clinical trials: two examples. Med Care. 1989;27(suppl):S190–S204
  15. Wakker P, Sitggelbout A. Explaining distortions in utility elicitation through the rank-dependent model for risky choices. Med Decis Making. 1995;15(2):180–186
  16. Richardson J. Cost utility analysis: what should be measured?. Soc Sci Med. 1994;39(1):7–21
  17. Brown GC. Vision and quality-of-life. Trans Am Ophthamol Soc. 1999;97:473–511
  18. Revicki DA, Kaplan DM. Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life. Qual Life Res. 1993;2(6):477–487
  19. Dohlman CH, Harissi-Dagher M, Khan BF, Sippel K, Aquavella JV, Graney JM. Introduction to the use of the Boston keratoprosthesis. Expert Rev Ophthalmol. 2006;1(1):41–48
  20. Dohlman C, Dudenhoefer E, Khan BF, Morneault S. Protection of the ocular surface after keratoprosthesis surgery: the role of soft contact lenses. CLAO J. 2002;28(2):72–74
  21. Zerbe BL, Belin MW, Ciolino JB Boston Type 1 Keratoprosthesis Study Group. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology. 2006;113(10):1779.e1–1779.e7
  22. Aldave AJ, Kamal KM, Vo RC, Yu F. The Boston Type I Keratoprosthesis (Improving outcomes and expanding indications). Ophthalmology. 2009;116(4):640–651
  23. Brezinski C, Zaglia R. Extrapolation methods. Appl Numer Math. 1994;15:123–131
  24. Schatzman M. Interpolation and divided differences. In:  Schatzman M editors. Numerical Analysis: A Mathematical Introduction. Oxford: Clarendon Press; 2002;p. 51–75
  25. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. In: New York: Oxford University Press; 1996;p. 1–413
  26. Brown MM, Brown GC, Sharma S, Garrett S. Evidence-based medicine, utilities, and quality of life. Curr Opin Ophthalmol. 1999;10(3):221–226
  27. McCabe C, Claxton K, Culyer AJ. The NICE cost-effectiveness threshold–What it is and what that means. Pharmacoeconomics. 2008;26(9):733–744
  28. Devlin N, Parkin D. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? (A binary choice analysis). Health Econ. 2004;13(5):437–452
  29. CPI Inflation Calculator. Washington, DC: U.S. Bureau of Labor Statistics; 2009;http://www.bls.gov/data/inflation_calculator.htmAccessed: March 14, 2009
  30. Busbee BG, Brown MM, Brown GC, Sharma S. Incremental cost-effectiveness of initial cataract surgery. Ophthalmology. 2002;109(3):606–612
  31. Busbee BG, Brown MM, Brown GC, Sharma S. Cost-utility analysis of cataract surgery in the second eye. Ophthalmology. 2003 Dec;110(12):2310–2317
  32. Sharma S, Brown GC, Brown MM, Hollands H, Shah GK. The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology. 2001;108(11):2051–2059
  33. Griffin SC, Barber JA, Manca A, et al. Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study. BMJ. 2007;334(7594):624–628
  34. Pinkerton SD, Holtgrave DR, Pinkerton HJ. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV. Arch Intern Med. 1997;157(17):1972–1980
  35. Dayton JD, Kanter KR, Vincent RN, Mahle WT. Cost-effectiveness of pediatric heart transplantation. J Heart Lung Transplant. 2006;25(4):409–415
  36. Mushlin AI, Mooney C, Holloway RG, Detsky AS, Mattson DH, Phelps CE. The cost-effectiveness of magnetic resonance imaging for patients with equivocal neurological symptoms. Int J Technol Assess Health Care. 1997;13(1):21–34
  37. Jacobson JJ, Schweitzer SO, Kowalski CJ. Chemoprophylaxis of prosthetic joint patients during dental treatment—a decision-utility analysis. Oral Surg Oral Med Oral Pathol. 1991;72(2):167–177
  38. Tabin GC, Gurung R, Paudyal G, et al. Penetrating keratoplasty in Nepal. Cornea. 2004;23(6):589–596
  39. Sharma N, Prakash G, Titiyal JS, Tandon R, Vajpayee RB. Pediatric keratoplasty in India: Indications and outcomes. Cornea. 2007;26(7):810–813
  40. Yorston D, Wood M, Foster A. Penetrating keratoplasty in Africa: graft survival and visual outcome. Br J Ophthalmol. 1996;80(10):890–894
  41. Ruit S, Tabin G, Chang D, et al. A prospective randomized clinical trial of phacoemulsification vs manual sutureless small-incision extracapsular cataract surgery in Nepal. Am J Ophthalmol. 2007;143(1):32–38

PII: S0002-9394(09)00627-8

doi: 10.1016/j.ajo.2009.08.027

American Journal of Ophthalmology
Volume 149, Issue 2 , Pages 221-228.e2 , 1 February 2010

Article Tools

* Image Usage & Resolution